4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-22-025509
CEO and President acquired 63,492 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Shaff Eric D. · CEO and President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-07-05 | Grant or award : show line 1 in the form | +63,492 | $3.15 | $200,000 | 96,334 | D |
Loading xslF345X03/doc4.xml…